| Название исследования |
Состояние |
|
| A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's |
Завершено |
|
| A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm?„?) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults |
Завершено |
|
| RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome |
Завершено |
|
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas |
Завершено |
|
| A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis |
Завершено |
|
| Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG) |
Отменено |
|
| A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease |
Завершено |
|
| The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) |
Идет набор |
|
| A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation |
Завершено |
|
| A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise |
Завершено |
|
| Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa |
Завершено |
|
| Asthma Exacerbation Study |
Идет набор |
|
| A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis. |
Завершено |
|
| SLV308 for Treatment of Patients With Early Parkinson's Disease |
Завершено |
|
| Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder |
Завершено |
|
| Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer |
Активный, набор окончен |
|
| SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations |
Завершено |
|
| An Extension Treatment Protocol for Subjects Who Have Participated in a Phase 3 Study of Tivozanib Versus Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301) |
Enrolling by invitation |
|
| Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression |
Отменено |
|
| Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients |
Идет набор |
|
| Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder |
Завершено |
|
| Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness |
Идет набор |
|
| Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia |
Отменено |
|
| A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis |
Enrolling by invitation |
|
| Ferinject?® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF) |
Завершено |
|
| Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients |
Завершено |
|
| Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder |
Завершено |
|
| Study to Assess the Safety of CDP870 for up to 84 Months Following Reintroduction of Treatment |
Активный, набор окончен |
|
| Efficacy of Alogliptin With Pioglitazone (Actos?®) in Subjects With Type 2 Diabetes Mellitus |
Завершено |
|
| Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) |
Активный, набор окончен |
|
| ABR-217620 With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma |
Активный, набор окончен |
|
| A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course |
Enrolling by invitation |
|
| Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients |
Идет набор |
|
| A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections |
Идет набор |
|
| Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders. |
Завершено |
|
| Evaluation of Tiotropium 5 ?µg/Day Delivered Via the Respimat?® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II) |
Активный, набор окончен |
|
| Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer |
Идет набор |
|
| RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag |
Завершено |
|
| Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib. |
Идет набор |
|
| A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery |
Завершено |
|
| Randomized, Double-Blind Active Comparator-Controlled Study of Rivoglitazone in Type 2 Diabetes Mellitus |
Завершено |
|
| Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis |
Активный, набор окончен |
|
| Respimat?® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) |
Завершено |
|
| BEYOND Follow-up: Betaferon?®/Betaseron?® Efficacy Yielding Outcomes of a New Dose |
Завершено |
|
| TroVax Renal Immunotherapy Survival Trial |
Завершено |
|
| First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX |
Активный, набор окончен |
|
| Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer |
Идет набор |
|
| Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma |
Активный, набор окончен |
|
| Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen |
Идет набор |
|
| Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma |
Активный, набор окончен |
|